Cortical thickness studies in migraine: Current evidence and future directions
Authors:
- Basit Ali ChaudhryBCBasit Ali Chaudhry
- Samaira YounisSYSamaira Younis
- Roberta MessinaRMRoberta Messina
- David García-AzorínDGDavid García-Azorín
- Nazia KarsanNKNazia Karsan
- Gianluca CoppolaGianluca Coppola
- Rune Häckert ChristensenRCRune Häckert Christensen
- Mohammad Mahdi Al-KaragholiMAMohammad Mahdi Al-Karagholi
- Patricia Pozo-RosichPPPatricia Pozo-Rosich
Open Access
- 6 June 2025
- journal article
- review article
- Published by SAGE Publications in Cephalalgia
- Vol. 45 (6)
Abstract
Background: Structural imaging offers insight into migraine pathogenesis. Magnetic resonance imaging (MRI) morphometry plays a crucial role in identifying these alterations, yet the clinical significance remains debated. While gray matter volume and cortical curvature are commonly analyzed, cortical thickness offers a more direct measure of cytoarchitectural differences and neuroplastic changes in migraine. Advanced structural MRI techniques, including surface-based morphometry and voxel-based morphometry, have provided insights into cortical thickness alterations in migraine. These methods enable high-resolution assessment of brain morphometry, revealing dynamic changes associated with migraine phases and treatment. Methods: This narrative review synthesizes findings from cortical thickness studies, focusing on methodological approaches, variations in imaging sequences and study designs, including cross-sectional and longitudinal studies. Results: Studies using surface-based morphometry (i.e. SBM) and voxel-based morphometry (i.e. VBM) have reported inconsistent findings. Increased thickness is frequently observed in pain-processing regions, such as the somatosensory cortex, insula and anterior cingulate cortex reflecting hyperexcitability or maladaptive neuroplasticity. by contrast, cortical thinning has been noted in regions such as the orbitofrontal cortex, posterior cingulate cortex and visual cortex, suggesting neuronal loss or impaired cortical integrity. Differences between episodic and chronic migraine further highlight progressive structural changes associated with disease burden. Emerging evidence also suggests that preventive treatments, including calcitonin gene-related peptide monoclonal antibodies and botulinum toxin A, may reverse some of these cortical alterations, particularly in treatment responders. Conclusions: Cortical thickness analysis provides valuable insights into migraine pathophysiology, offering a potential biomarker for disease progression and treatment response. However, inconsistencies across studies highlight the need for standardized MRI protocols and larger longitudinal investigations to clarify the clinical relevance of cortical thickness changes in migraine.Keywords
Funding Information
- Lundbeck Foundation (R396-2022-301)
This publication has 54 references indexed in Scilit:
- Structural brain changes in patients with persistent headache after COVID-19 resolutionJournal of Neurology, 2022
- A systematic review and meta-analysis of voxel-based morphometric studies of migraineJournal of Neurology, 2022
- A comparison of methods to harmonize cortical thickness measurements across scanners and sitesNeuroImage, 2022
- Comparison of structural MRI brain measures between 1.5 and 3 T: Data from the Lothian Birth Cohort 1936Human Brain Mapping, 2021
- Cortical thickness asymmetries and surgical outcome in neocortical epilepsyJournal of the Neurological Sciences, 2016
- Sensory migraine aura is not associated with structural grey matter abnormalitiesNeuroImage: Clinical, 2016
- Genetic contribution of catechol‐O‐methyltransferase in hippocampal structural and functional changes of female migraine sufferersHuman Brain Mapping, 2015
- Structural brain MRI abnormalities in pediatric patients with migraineJournal of Neurology, 2013
- Structural and functional abnormalities in migraine patients without auraNMR in Biomedicine, 2012
- Comparing surface-based and volume-based analyses of functional neuroimaging data in patients with schizophreniaNeuroImage, 2008